Zobrazeno 1 - 10
of 349
pro vyhledávání: '"Guillermo, Quindós"'
Autor:
Mariem Chamtouri, Abderrahmen Merghni, Katherine Miranda-Cadena, Nabil Sakly, Naoufel Gaddour, Clara G. de Los Reyes-Gavilán, Maha Mastouri, Elena Eraso, Guillermo Quindós
Publikováno v:
Journal of Fungi, Vol 10, Iss 11, p 730 (2024)
Research on the microbiota–gut–brain axis in autism has primarily focused on bacteria, with limited attention to fungi. There is a growing interest in understanding the involvement of fungi, particularly Candida, in patients with autism spectrum
Externí odkaz:
https://doaj.org/article/6f0c117a1cc846079bf72df74ef5ceac
Autor:
Ainara Hernando-Ortiz, Elena Eraso, Nerea Jauregizar, Piet W.J. de Groot, Guillermo Quindós, Estibaliz Mateo
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT The multidrug-resistant Candida auris is a global health emergency, being responsible for outbreaks of invasive candidiasis worldwide. Limited effective therapeutic options make it difficult to treat this emerging pathogen. In this context,
Externí odkaz:
https://doaj.org/article/d30879d713674224b78cd0bc15feb3e3
Autor:
Unai Caballero, Elena Eraso, Guillermo Quindós, Valvanera Vozmediano, Stephan Schmidt, Nerea Jauregizar
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 6, Pp 770-782 (2023)
Abstract In vitro combination of echinocandins and isavuconazole against the emerging species Candida auris is mainly synergistic. However, this combination has not been evaluated in clinical settings. A pharmacokinetic/pharmacodynamic modeling and s
Externí odkaz:
https://doaj.org/article/c5d5753bcfc74921aed47867cd1ff918
Autor:
Asier Ramos‐Pardo, Rocío Castro‐Álvarez, Guillermo Quindós, Elena Eraso, Elena Sevillano, Vladimir R. Kaberdin
Publikováno v:
MicrobiologyOpen, Vol 12, Iss 1, Pp n/a-n/a (2023)
Abstract Candida albicans is an opportunistic pathogen that can thrive under adverse conditions including suboptimal pH, nutrient scarcity, and low levels of oxygen. Its pathogenicity is associated with the production of virulence factors such as ext
Externí odkaz:
https://doaj.org/article/6d66e1a97ebb4002bf348943aae480ac
Autor:
Ainara Hernando-Ortiz, Estibaliz Mateo, Aitzol Perez-Rodriguez, Piet W.J. de Groot, Guillermo Quindós, Elena Eraso
Publikováno v:
Virulence, Vol 12, Iss 1, Pp 1063-1075 (2021)
Candida auris is an emerging multidrug-resistant fungal pathogen responsible for nosocomial outbreaks of invasive candidiasis. Although several studies on the pathogenicity of this species have been reported, the knowledge on C. auris virulence is st
Externí odkaz:
https://doaj.org/article/11ccbd8ed4564da4bcad0a737bce01d4
Autor:
Katherine Miranda-Cadena, Cristina Marcos-Arias, Aitzol Perez-Rodriguez, Iván Cabello-Beitia, Estibaliz Mateo, Elena Sevillano, Lucila Madariaga, Guillermo Quindós, Elena Eraso
Publikováno v:
Journal of Oral Microbiology, Vol 14, Iss 1 (2022)
Background The ability of Candida to develop biofilms on inert surfaces or living tissues favors recalcitrant and chronic candidiasis associated, in many instances, with resistance to current antifungal therapy.Aim The aim of this study was to evalua
Externí odkaz:
https://doaj.org/article/c7e63809932c49539c009550f1c586b2
Autor:
Irene Lafuente-Ibáñez de Mendoza, Amaia Cayero-Garay, Guillermo Quindós-Andrés, José Manuel Aguirre-Urizar
Publikováno v:
International Journal of Implant Dentistry, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background Candida is a heterogeneous fungal genus. Subgingival sulcus is a refuge for Candida, which has already been related to the pathogenic inflammation of periodontitis. This work aims to review the presence of Candida in the sulcular
Externí odkaz:
https://doaj.org/article/e5b91c68e1524a49ac078a5a1d0c2673
Autor:
Iñigo de-la-Fuente, Andrea Guridi, Nerea Jauregizar, Elena Eraso, Guillermo Quindós, Elena Sevillano
Publikováno v:
Journal of Fungi, Vol 9, Iss 6, p 648 (2023)
Candida auris is an emerging fungal pathogen responsible for hospital outbreaks of invasive candidiasis associated with high mortality. The treatment of these mycoses is a clinical challenge due to the high resistance levels of this species to curren
Externí odkaz:
https://doaj.org/article/3899a862be1841cebfd1cbbc67b0c91d
Autor:
Guillermo Quindós, Katherine Miranda-Cadena, Rosario San-Millán, Katyna Borroto-Esoda, Emilia Cantón, María José Linares-Sicilia, Axel Hamprecht, Isabel Montesinos, Anna Maria Tortorano, Anna Prigitano, Matxalen Vidal-García, Cristina Marcos-Arias, Andrea Guridi, Ferran Sanchez-Reus, Jesús Machuca-Bárcena, Manuel Antonio Rodríguez-Iglesias, Estrella Martín-Mazuelos, Carmen Castro-Méndez, Leyre López-Soria, Alba Ruiz-Gaitán, Marcelo Fernandez-Rivero, Damaris Lorenzo, Javier Capilla, Antonio Rezusta, Javier Pemán, Josep Guarro, Joana Pereira, Célia Pais, Orazio Romeo, Guillermo Ezpeleta, Nerea Jauregizar, David Angulo, Elena Eraso
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
BackgroundIbrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis.ObjectiveThe aim of this study was to assess the in vitro activity of ibrexafunger
Externí odkaz:
https://doaj.org/article/e8acd3ce6c82467e841c39ae806f8221
Autor:
Nerea Jauregizar, Guillermo Quindós, Sandra Gil-Alonso, Elena Suárez, Elena Sevillano, Elena Eraso
Publikováno v:
Journal of Fungi, Vol 8, Iss 7, p 727 (2022)
The study of the pharmacological properties of an antifungal agent integrates the drug pharmacokinetics, the fungal growth inhibition, the fungicidal effect and the postantifungal activity, laying the basis to guide optimal dosing regimen selection.
Externí odkaz:
https://doaj.org/article/7f978b1b1e994374ae392ff641cbcf11